No Data
No Data
Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)
Express News | Poseida Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
Piper Sandler Reaffirms Their Buy Rating on Poseida Therapeutics (PSTX)
Poseida Therapeutics: A Strong Buy on Robust Pipeline, Strategic Partnerships, and Leadership Enhancements
Express News | Poseida Therapeutics Inc: Expects Current Cash, Cash Equivalents and Short-Term Investments Sufficient to Fund Operations Into Second Half of 2025
Poseida Therapeutics | 10-Q: Quarterly report